Jump to content

Jacques Servier

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Citation bot (talk | contribs) at 20:38, 22 October 2020 (Add: work. Removed parameters. Some additions/deletions were actually parameter name changes. | You can use this bot yourself. Report bugs here. | Suggested by AManWithNoPlan | All pages linked from cached copy of User:AManWithNoPlan/sandbox4 | via #UCB_webform_linked 1358/2209). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Jacques Servier
Born(1922-02-09)9 February 1922
Died16 April 2014(2014-04-16) (aged 92)
NationalityFrench
Occupation(s)Businessman
Founder of Laboratoires Servier

Jacques Servier (9 February 1922 – 16 April 2014) was a French doctor and businessman. He was the founder and president of Laboratoires Servier, a pharmaceutical company.[1]

Biography

Founder of the pharmaceutical group Servier in 1954, he had a fortune estimated at US$7.7 billion.[2]

The group led by him, Servier, had been convicted several times to pay damages for Mediator, trade name of benfluorex. There was a class action also for Isoméride, trade name of dexfenfluramine. There are also active discussions and trial around benfluorex.[3][4]

Decorations

References

  1. ^ Bloomberg BusinessWeek
  2. ^ "Jacques Servier - Forbes". Forbes. Retrieved 16 April 2014.
  3. ^ "French patients sue over weight-loss drug linked to deaths". The Guardian. 24 November 2010.
  4. ^ Mullard A (March 2011). "Mediator scandal rocks French medical community" (PDF). Lancet. Vol. 377, no. 9769. pp. 890–892. PMID 21409784. Archived from the original (PDF) on 2012-05-25.
  5. ^ "Sarkozy vows health system fix after drug furore". AlertNet. 20 January 2011. Archived from the original on 14 June 2012. Retrieved 24 September 2011.